The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe
Open accessAbstract
BACKGROUND: Resource utilisation and direct costs associated with glaucoma progression in Europe are unknown. As population progressively ages, the economic impact of the disease will increase. METHODS: From a total of 1655 consecutive cases, the records of 194 patients were selected and stratified by disease severity. Record selection was based on diagnoses of primary open angle glaucoma, glaucoma suspect, ocular hypertension, or normal tension glaucoma; 5 years minimum follow up were required. Glaucoma severity was assessed using a six stage glaucoma staging system based on static threshold visual field parameters. Resource utilisation data were abstracted from the charts and unit costs were applied to estimate direct costs to the payer. Resource utilisation and estimated direct cost of treatment, per person year, were calculated. RESULTS: A statistically significant increasing linear trend (p = 0.018) in direct cost as disease severity worsened was demonstrated. The direct cost of treatment increased by an estimated 86 for each incremental step ranging from 455 euro per person year for stage 0 to 969 euro per person year for stage 4 disease. Medication costs ranged from 42% to 56% of total direct cost for all stages of disease. CONCLUSIONS: These results demonstrate for the first time in Europe that resource utilisation and direct medical costs of glaucoma management increase with worsening disease severity. Based on these findings, managing glaucoma and effectively delaying disease progression would be expected to significantly reduce the economic burden of this disease. These data are relevant to general practitioners and healthcare administrators who have a direct influence on the distribution of resources.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Number of people with glaucoma worldwide.
Quigley, H. A. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.5.389 · Cited by 2,998
Factors for Glaucoma Progression and the Effect of Treatment: The Early Manifest Glaucoma Trial
Leske, M. C. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.1.48 · Cited by 2,030
Klein, R., Klein, B. E. K., Moss, S. E., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32011-1 · Cited by 1,340
Lichter, P. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00873-9 · Cited by 1,178
Klein, B. E. K., Klein, R., Sponsel, W. E., Franke, T., Cantor, L. B., Martone, J., & Menage, M. J. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31774-9 · Cited by 967
Racial Variations in the Prevalence of Primary Open-angle Glaucoma: The Baltimore Eye Survey
Tielsch, J. M. (1991) · JAMA · doi:10.1001/jama.1991.03470030069026 · Cited by 879
Racial Differences in the Cause-Specific Prevalence of Blindness in East Baltimore
Sommer, A., Tielsch, J. M., Katz, J., Quigley, H. A., Gottsch, J. D., Javitt, J. C., Martone, J. F., Royall, R. M., Witt, K. A., & Ezrine, S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111143252004 · Cited by 764
The Barbados Eye Study: Prevalence of Open Angle Glaucoma
Leske, M. C. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090180121046 · Cited by 685
Terminology and guidelines for glaucoma
Molina-Castañer, S. (2009) · Hispana · Cited by 665
The Prevalence of Primary Open-angle Glaucoma in a Population-based Study in The Netherlands
Dielemans, I., Vingerling, J. R., Wolfs, R. C. W., Hofman, A., Grobbee, D. E., & de Jong, P. T. V. M. (1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31090-6 · Cited by 610
Cited by
Burr, J., Mowatt, G., Hernández, R., Siddiqui, M., Cook, J., Lourenco, T., Ramsay, C., Vale, L., Fraser, C., Azuara-Blanco, A., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11410 · Cited by 549
Categorizing the Stage of Glaucoma From Pre-Diagnosis to End-Stage Disease
Mills, R. P., Budenz, D. L., Lee, P. P., Noecker, R. J., Walt, J. G., Siegartel, L. R., Evans, S. J., & Doyle, J. J. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.07.044 · Cited by 484
An Assessment of the Health and Economic Burdens of Glaucoma
Varma, R., Lee, P. P., Goldberg, I., & Kotak, S. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.06.004 · Cited by 390
Categorizing the Stage of Glaucoma From Prediagnosis to End-Stage Disease
Brusini, P. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.03.002 · Cited by 336
Lee, P. P. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.1.12 · Cited by 255
Epidemiology of Major Eye Diseases Leading to Blindness in Europe: A Literature Review
Prokofyeva, E., & Zrenner, E. (2012) · Ophthalmic Research · doi:10.1159/000329603 · Cited by 212
Surveillance for ocular hypertension: an evidence synthesis and economic evaluation.
Burr, J., Botello-Pinzon, P., Takwoingi, Y., Hernández, R., Vazquez-Montes, M., Elders, A., Asaoka, R., Banister, K., van der Schoot, J., Fraser, C., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16290 · Cited by 180
Patel, P. J., Ziemssen, F., Ng, E., Muthutantri, A., Silverman, D., Tschosik, E. A., & Cantrell, R. A. (2020) · Clinical Ophthalmology · doi:10.2147/opth.s226425 · Cited by 61
Metadata
- Authors
- Traverso, C. E.
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 2005-10-01
- Volume
- 89
- Issue
- 10
- Pages
- 1245-1249
- ISSN
- 0007-1161 (ISSN-L)
- OpenAlex
- W2149352344
- Cited by
- 273
- References
- 24
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.